{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T12:04:27Z","timestamp":1789387467838,"version":"build-2803163510"},"reference-count":30,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,29]],"date-time":"2023-11-29T00:00:00Z","timestamp":1701216000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100016304","name":"Medtronic Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016304","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004374","name":"Medtronic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004374","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","onlinecjc.ca","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Canadian Journal of Cardiology"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.cjca.2023.11.019","type":"journal-article","created":{"date-parts":[[2023,11,23]],"date-time":"2023-11-23T18:09:13Z","timestamp":1700762953000},"page":"576-584","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["The Cost-Effectiveness of First-Line Cryoablation vs First-Line Antiarrhythmic Drugs in Canadian Patients With Paroxysmal Atrial Fibrillation"],"prefix":"10.1016","volume":"40","author":[{"given":"Jason G.","family":"Andrade","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joe W.E.","family":"Moss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malte","family":"Kuniss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamid","family":"Sadri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oussama","family":"Wazni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-3394-5246","authenticated-orcid":false,"given":"Alicia","family":"Sale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleni","family":"Ismyrloglou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gian Battista","family":"Chierchia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachelle","family":"Kaplon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart","family":"Mealing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie","family":"Bainbridge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Bromilow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Lane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaariv","family":"Khaykin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cjca.2023.11.019_bib1","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1177\/1747493019897870","article-title":"Global epidemiology of atrial fibrillation: an increasing epidemic and public health challenge","volume":"16","author":"Lippi","year":"2021","journal-title":"Int J Stroke"},{"key":"10.1016\/j.cjca.2023.11.019_bib2","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1093\/ehjqcco\/qcaa061","article-title":"Global, regional, and national prevalence, incidence, mortality, and risk factors for atrial fibrillation, 1990-2017: results from the Global Burden of Disease Study 2017","volume":"7","author":"Dai","year":"2021","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"10.1016\/j.cjca.2023.11.019_bib3","doi-asserted-by":"crossref","first-page":"3042","DOI":"10.3390\/ijerph16173042","article-title":"Health-related quality of life and associated factors in patients with atrial fibrillation: an integrative literature review","volume":"16","author":"Son","year":"2019","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.cjca.2023.11.019_bib4","doi-asserted-by":"crossref","first-page":"k1717","DOI":"10.1136\/bmj.k1717","article-title":"Risk of stroke and transient ischaemic attack in patients with a diagnosis of resolved atrial fibrillation: retrospective cohort studies","volume":"361","author":"Adderley","year":"2018","journal-title":"BMJ"},{"key":"10.1016\/j.cjca.2023.11.019_bib5","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1177\/2047487317715769","article-title":"Atrial fibrillation and the risk for myocardial infarction, all-cause mortality and heart failure: a systematic review and meta-analysis","volume":"24","author":"Ruddox","year":"2017","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.cjca.2023.11.019_bib6","first-page":"229","article-title":"The burden of atrial fibrillation on the hospital sector in Canada","volume":"29","author":"O\u2019Reilly","year":"2013","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2023.11.019_bib7","first-page":"1094","article-title":"Reducing the burden of atrial fibrillation cost: is integrated care the answer?","volume":"35","author":"Gallagher","year":"2019","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2023.11.019_bib8","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1093\/ehjqcco\/qcaa093","article-title":"Atrial fibrillation in the UK: predicting costs of an emerging epidemic recognizing and forecasting the cost drivers of atrial fibrillation-related costs","volume":"8","author":"Burdett","year":"2022","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"10.1016\/j.cjca.2023.11.019_bib9","first-page":"1847","article-title":"The 2020 Canadian Cardiovascular Society\/Canadian Heart Rhythm Society comprehensive guidelines for the management of atrial fibrillation","volume":"36","author":"Andrade","year":"2020","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2023.11.019_bib10","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1056\/NEJMoa2029980","article-title":"Cryoablation or drug therapy for initial treatment of atrial fibrillation","volume":"384","author":"Andrade","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2023.11.019_bib11","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1056\/NEJMoa2029554","article-title":"Cryoballoon ablation as initial therapy for atrial fibrillation","volume":"384","author":"Wazni","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2023.11.019_bib12","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1093\/europace\/euab029","article-title":"Cryoballoon ablation vs antiarrhythmic drugs: first-line therapy for patients with paroxysmal atrial fibrillation","volume":"23","author":"Kuniss","year":"2021","journal-title":"Europace"},{"key":"10.1016\/j.cjca.2023.11.019_bib13","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.hroo.2023.07.007","article-title":"An economic evaluation of first-line cryoballoon ablation versus antiarrhythmic drug therapy for the treatment of paroxysmal atrial fibrillation from a united states medicare perspective","volume":"4","author":"Wazni","year":"2023","journal-title":"Heart Rhythm O2"},{"key":"10.1016\/j.cjca.2023.11.019_bib14","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","volume":"42","author":"Hindricks","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2023.11.019_bib16","doi-asserted-by":"crossref","first-page":"445","DOI":"10.2147\/CEOR.S264589","article-title":"Can standard health technology assessment approaches help guide the price of orphan drugs in Canada? A review of submissions to the Canadian Agency for Drugs and Technologies in Health Common Drug Review","volume":"12","author":"Balijepalli","year":"2020","journal-title":"Clinicoecon Outcomes Res"},{"key":"10.1016\/j.cjca.2023.11.019_bib22","series-title":"Self-Reported Population Health: An International Perspective Based on EQ-5D","first-page":"162","year":"2014"},{"key":"10.1016\/j.cjca.2023.11.019_bib23","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000016560","article-title":"Predictive value of CHA2DS2-VASc scores regarding the risk of stroke and all-cause mortality in patients with atrial fibrillation (CONSORT compliant)","volume":"98","author":"Gazova","year":"2019","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.cjca.2023.11.019_bib24","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/europace\/eux274","article-title":"2017 HRS\/EHRA\/ECAS\/APHRS\/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation","volume":"20","author":"Calkins","year":"2018","journal-title":"Europace"},{"key":"10.1016\/j.cjca.2023.11.019_bib25","first-page":"1425","article-title":"An analysis of the cost-effectiveness of transcatheter mitral valve repair for people with secondary mitral valve regurgitation in the UK","volume":"23","author":"Shore","year":"2020","journal-title":"J\u00a0Med Econ"},{"key":"10.1016\/j.cjca.2023.11.019_bib26","article-title":"Cost-utility of catheter ablation for atrial fibrillation in patients with heart failure: an economic evaluation","volume":"10","author":"Lau","year":"2021","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.cjca.2023.11.019_bib27","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1093\/europace\/eut395","article-title":"The European Heart Rhythm Association symptom classification for atrial fibrillation: validation and improvement through a simple modification","volume":"16","author":"Wynn","year":"2014","journal-title":"Europace"},{"key":"10.1016\/j.cjca.2023.11.019_bib28","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1540-8167.2008.01303.x","article-title":"Cost comparison of ablation versus antiarrhythmic drugs as first-line therapy for atrial fibrillation: an economic evaluation of the RAAFT pilot study","volume":"20","author":"Khaykin","year":"2009","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.cjca.2023.11.019_bib29","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euad074","article-title":"Variation and clinical consequences of wait-times for atrial fibrillation ablation: population level study in Ontario, Canada","volume":"25","author":"Qeska","year":"2023","journal-title":"Europace"},{"key":"10.1016\/j.cjca.2023.11.019_bib30","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1093\/eurheartj\/ehu028","article-title":"Early management of atrial fibrillation to prevent cardiovascular complications","volume":"35","author":"Nattel","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2023.11.019_bib32","author":"Exchange Rates UK"},{"key":"10.1016\/j.cjca.2023.11.019_bib33","first-page":"1","article-title":"Left atrial appendage closure device with delivery system: a health technology assessment","volume":"17","year":"2017","journal-title":"Ont Health Technol Assess Ser"},{"key":"10.1016\/j.cjca.2023.11.019_bib34","author":"Exchange Rates UK"},{"key":"10.1016\/j.cjca.2023.11.019_bib35","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0226730","article-title":"Health-related quality of life in patients with atrial fibrillation: the role of symptoms, comorbidities, and the type of atrial fibrillation","volume":"14","author":"Witassek","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.cjca.2023.11.019_bib36","doi-asserted-by":"crossref","first-page":"127","DOI":"10.2217\/cer-2020-0224","article-title":"Cost-effectiveness of an insertable cardiac monitor to detect atrial fibrillation in patients with cryptogenic stroke","volume":"10","author":"Sawyer","year":"2021","journal-title":"J\u00a0Comp Eff Res"},{"key":"10.1016\/j.cjca.2023.11.019_bib37","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1524-4733.2008.00425.x","article-title":"Utility estimates for decision-analytic modeling in chronic heart failure\u2014health states based on New York Heart Association classes and number of rehospitalizations","volume":"12","author":"Gohler","year":"2009","journal-title":"Value Health"}],"container-title":["Canadian Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X23019402?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X23019402?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T11:14:01Z","timestamp":1789384441000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0828282X23019402"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S0828282X23019402"],"URL":"https:\/\/doi.org\/10.1016\/j.cjca.2023.11.019","relation":{},"ISSN":["0828-282X"],"issn-type":[{"value":"0828-282X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Cost-Effectiveness of First-Line Cryoablation vs First-Line Antiarrhythmic Drugs in Canadian Patients With Paroxysmal Atrial Fibrillation","name":"articletitle","label":"Article Title"},{"value":"Canadian Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cjca.2023.11.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc. on behalf of the Canadian Cardiovascular Society.","name":"copyright","label":"Copyright"}]}}